Biomed Industries integrates MedAware Systems into its Biomed AI Subsidiary

SAN JOSE, Calif. - April 11, 2023 - PRLog -- Biomed Industries, Inc. (BIOMED) announced today that its recent acquisition of Boulder CO based MedAware Systems, Inc. is now complete. MedAware Systems will be integrated into the Company's AI subsidiary, Biomed AI Inc.

Biomed AI aims to fully integrate Human Real-World Evidence (HRWE) data across the entire drug development and clinical trial life cycle, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The Biomed AI Platform™ applies state-of-the-art Machine Learning and Artificial Intelligence, including CHAT-GPT-4, to transform data into valuable insights. The first application of the Platform is in advancing robust pipeline development for BIOMED's programs for treatment and prevention of neurodegenerative diseases.

Additionally, MedAware Systems' SOHInfo business will be branded as BiomedAI Reports. These automated, AI-powered reports support Medical Device and Pharmaceutical companies with rapid and cost-effective data acquisition and reporting for regulatory filings and business intelligence.

"Biomed AI aggregates and analyzes massive quantities of data from published medical research, government databases, and real-world patients records and other data sources at rates and volumes unmatched in the industry", said Dr. Zung Tran, Vice President of Biomed AI. He continued: "Through the application of AI algorithms for the analysis of massive datasets, we are developing predictive models for both drug development and clinical trials recruiting and outcomes."

About Biomed Industries, Inc.

Biomed Industries™, Inc. is a bio-pharmaceutical company committed to the development and commercialization of new drug therapeutics for unmet needs. Biomed is a leading innovator, having discovered a new family of clinical stage drugs for the treatment of Alzheimer's disease. The Company is also developing new applications of AI for drug discovery, clinical trials recruitment and execution, and other mission critical areas in the pharmaceutical and medical device industry. For more information, please visit https://www.biomedind.com